(XPEV) Xpeng - Ratings and Ratios

Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US98422D1054

Electric, Sedan, SUV, MPV, Platform

XPEV EPS (Earnings per Share)

EPS (Earnings per Share) of XPEV over the last years for every Quarter: "2020-09": -2.16, "2020-12": -0.95, "2021-03": -0.88, "2021-06": -1.38, "2021-09": -1.77, "2021-12": -1.41, "2022-03": -1.8, "2022-06": -3.16, "2022-09": -2.77, "2022-12": -2.76, "2023-03": -2.71, "2023-06": -3.25, "2023-09": -4.49, "2023-12": -1.51, "2024-03": -1.45, "2024-06": -1.36, "2024-09": -1.62, "2024-12": -1.47, "2025-03": -0.45, "2025-06": -0.2, "2025-09": 0,

XPEV Revenue

Revenue of XPEV over the last years for every Quarter: 2020-09: 1990.119, 2020-12: 2851.352, 2021-03: 2950.926, 2021-06: 3761.279, 2021-09: 5719.918, 2021-12: 8556.008, 2022-03: 7454.938, 2022-06: 7436.345, 2022-09: 6823.487, 2022-12: 5140.349, 2023-03: 4033.42, 2023-06: 5062.696, 2023-09: 8529.521, 2023-12: 13050.43, 2024-03: 6548.096, 2024-06: 8111.407, 2024-09: 10101.71, 2024-12: 16105.096, 2025-03: 15810.628, 2025-06: 18274.405, 2025-09: null,

Description: XPEV Xpeng

XPeng Inc. (NYSE:XPEV) designs, develops, manufactures, and markets a portfolio of smart electric vehicles (EVs) in China, including the P7/P7i sports sedan, G9 and G6 SUVs, X9 seven-seater MPV, MONA M03 hatchback coupe, and the performance-oriented P7+. The firm also supplies its proprietary XOS Tianji in-car operating system, the SEPA 2.0 electric platform, and a suite of ancillary services such as supercharging, maintenance, insurance tech, and auto-financing.

Recent data (Q3 2024) show XPeng delivered roughly 38,000 vehicles, a year-over-year increase of about 30 % and the strongest growth among domestic EV makers, while R&D spending rose to ~4.5 billion RMB, reflecting its push on autonomous driving and battery-efficiency technologies. The Chinese EV market is expanding at ~20 % CAGR, but the pace of government subsidies is tapering, making cost-competitiveness and software differentiation increasingly critical for market share.

For a deeper, data-driven assessment of XPeng’s valuation dynamics-including forward-looking cash-flow models and scenario analysis-consider exploring the detailed analyst toolkit on ValueRay.

XPEV Stock Overview

Market Cap in USD 21,320m
Sub-Industry Automobile Manufacturers
IPO / Inception 2020-08-27

XPEV Stock Ratings

Growth Rating 51.2%
Fundamental 39.7%
Dividend Rating -
Return 12m vs S&P 500 79.6%
Analyst Rating 4.21 of 5

XPEV Dividends

Currently no dividends paid

XPEV Growth Ratios

Growth Correlation 3m 73.6%
Growth Correlation 12m 74%
Growth Correlation 5y -59.1%
CAGR 5y 38.05%
CAGR/Max DD 3y (Calmar Ratio) 0.53
CAGR/Mean DD 3y (Pain Ratio) 1.11
Sharpe Ratio 12m 0.56
Alpha 55.93
Beta 2.531
Volatility 63.56%
Current Volume 4617.5k
Average Volume 20d 6493.6k
Stop Loss 20 (-5.7%)
Signal 0.15

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (-4.28b TTM) > 0 and > 6% of Revenue (6% = 3.62b TTM)
FCFTA -0.05 (>2.0%) and ΔFCFTA -4.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 11.29% (prev 41.22%; Δ -29.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.02 (>3.0%) and CFO -2.01b > Net Income -4.28b (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (951.2m) change vs 12m ago -49.62% (target <= -2.0% for YES)
Gross Margin 15.75% (prev 7.07%; Δ 8.68pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 72.02% (prev 48.32%; Δ 23.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -9.84 (EBITDA TTM -2.78b / Interest Expense TTM 537.3m) >= 6 (WARN >= 3)

Altman Z'' -2.13

(A) 0.07 = (Total Current Assets 54.77b - Total Current Liabilities 47.96b) / Total Assets 92.43b
(B) -0.46 = Retained Earnings (Balance) -42.74b / Total Assets 92.43b
(C) -0.06 = EBIT TTM -5.28b / Avg Total Assets 83.71b
(D) -0.65 = Book Value of Equity -40.58b / Total Liabilities 62.09b
Total Rating: -2.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 39.67

1. Piotroski 3.50pt = -1.50
2. FCF Yield -2.99% = -1.49
3. FCF Margin -7.36% = -2.76
4. Debt/Equity 1.01 = 2.01
5. Debt/Ebitda -4.27 = -2.50
6. ROIC - WACC (= -23.85)% = -12.50
7. RoE -13.77% = -2.29
8. Rev. Trend 83.40% = 6.26
9. EPS Trend 89.08% = 4.45

What is the price of XPEV shares?

As of October 18, 2025, the stock is trading at USD 21.20 with a total of 4,617,462 shares traded.
Over the past week, the price has changed by +0.86%, over one month by -1.85%, over three months by +16.36% and over the past year by +107.44%.

Is Xpeng a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Xpeng (NYSE:XPEV) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 39.67 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XPEV is around 17.86 USD . This means that XPEV is currently overvalued and has a potential downside of -15.75%.

Is XPEV a buy, sell or hold?

Xpeng has received a consensus analysts rating of 4.21. Therefore, it is recommended to buy XPEV.
  • Strong Buy: 14
  • Buy: 7
  • Hold: 6
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the XPEV price?

Issuer Target Up/Down from current
Wallstreet Target Price 26.4 24.5%
Analysts Target Price 26.4 24.5%
ValueRay Target Price 20.7 -2.5%

Last update: 2025-10-13 02:03

XPEV Fundamental Data Overview

Market Cap CNY = 151.88b (21.32b USD * 7.124 USD.CNY)
P/E Forward = 59.8802
P/S = 0.3536
P/B = 5.3256
Beta = 2.531
Revenue TTM = 60.29b CNY
EBIT TTM = -5.28b CNY
EBITDA TTM = -2.78b CNY
Long Term Debt = 5.79b CNY (from longTermDebt, last quarter)
Short Term Debt = 19.67b CNY (from shortTermDebt, last quarter)
Debt = 30.67b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.86b CNY (from netDebt column, last quarter)
Enterprise Value = 148.69b CNY (151.88b + Debt 30.67b - CCE 33.87b)
Interest Coverage Ratio = -9.84 (Ebit TTM -5.28b / Interest Expense TTM 537.3m)
FCF Yield = -2.99% (FCF TTM -4.44b / Enterprise Value 148.69b)
FCF Margin = -7.36% (FCF TTM -4.44b / Revenue TTM 60.29b)
Net Margin = -7.10% (Net Income TTM -4.28b / Revenue TTM 60.29b)
Gross Margin = 15.75% ((Revenue TTM 60.29b - Cost of Revenue TTM 50.80b) / Revenue TTM)
Gross Margin QoQ = 17.33% (prev 15.56%)
Tobins Q-Ratio = 1.61 (Enterprise Value 148.69b / Total Assets 92.43b)
Interest Expense / Debt = 0.25% (Interest Expense 75.2m / Debt 30.67b)
Taxrate = 1.93% (-9.42m / -487.2m)
NOPAT = -5.18b (EBIT -5.28b * (1 - 1.93%)) [loss with tax shield]
Current Ratio = 1.14 (Total Current Assets 54.77b / Total Current Liabilities 47.96b)
Debt / Equity = 1.01 (Debt 30.67b / totalStockholderEquity, last quarter 30.34b)
Debt / EBITDA = -4.27 (negative EBITDA) (Net Debt 11.86b / EBITDA -2.78b)
Debt / FCF = -2.67 (negative FCF - burning cash) (Net Debt 11.86b / FCF TTM -4.44b)
Total Stockholder Equity = 31.09b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.63% (Net Income -4.28b / Total Assets 92.43b)
RoE = -13.77% (Net Income TTM -4.28b / Total Stockholder Equity 31.09b)
RoCE = -14.33% (EBIT -5.28b / Capital Employed (Equity 31.09b + L.T.Debt 5.79b))
RoIC = -11.04% (negative operating profit) (NOPAT -5.18b / Invested Capital 46.93b)
WACC = 12.80% (E(151.88b)/V(182.56b) * Re(15.34%) + D(30.67b)/V(182.56b) * Rd(0.25%) * (1-Tc(0.02)))
Discount Rate = 15.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -28.65%
Fair Price DCF = unknown (Cash Flow -4.44b)
EPS Correlation: 89.08 | EPS CAGR: 38.91% | SUE: 0.67 | # QB: 0
Revenue Correlation: 83.40 | Revenue CAGR: 43.08% | SUE: 0.04 | # QB: 0

Additional Sources for XPEV Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle